Opinion: Making Room for Rising Stars

Dealing with the delicate matter of retirement for aging academics

Written byBrad Fenwick
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

FLICKR, EASYLOCUMOne lasting effect of the great recession of 2008 is the now unemployed baby boomers, who were either forced into early retirement or outright saw their jobs disappear. Left in employment limbo of being “too old to hire but too young to retire,” the 55+ crowd—who, at one time made up about 40 percent of the workforce—was left with the almost impossible task of competing with the 20-something college graduates.

But what of the academic sector? Is the perception that tenure protects the academic elite from the harsh realities of life in private enterprise, based in reality? Indeed, at age 91 Leon Lederman still commands respect as an active scientist, as do Eric Kandel (84), James Watson (85), and E.O. Wilson (84). While most researchers do not have the high-profile credentials of these science luminaries, nevertheless many academics continue to contribute to their fields well into their so-called retirement years, their productivity keeping them safe from forced retirement through post-tenure review processes. What happens, then, to the 20-somethings looking for those elusive research positions and coming up short-changed because of reluctance by senior faculty and administrators to hang up their lab coats?

Research positions, even ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies